We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+24.09%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+648.16%
AUM
$30.1B
AUM Growth
+$18.1B
Cap. Flow
+$14.4B
Cap. Flow %
47.94%
Top 10 Hldgs %
24.14%
Holding
1,348
New
61
Increased
986
Reduced
178
Closed
82

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$819M
2
AAPL icon
Apple
AAPL
+$774M
3
AMZN icon
Amazon
AMZN
+$413M
4
BABA icon
Alibaba
BABA
+$291M
5
UNH icon
UnitedHealth
UNH
+$263M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$80.3M
2
AZO icon
AutoZone
AZO
+$19.9M
3
NRG icon
NRG Energy
NRG
+$19.1M
4
PARA
Paramount Global Class B
PARA
+$12.3M
5
COF icon
Capital One
COF
+$11.8M

Sector Composition

Rank Sector Weight
1 Technology 27.44%
2 Healthcare 18.82%
3 Financials 12.15%
4 Consumer Discretionary 11.28%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPI
1201
DELISTED
Office Properties Income Trust
OPI
$68K ﹤0.01%
2,594
+1,297
+100% +$33.8K
GHL
1202
DELISTED
Greenhill & Co., Inc.
GHL
$68K ﹤0.01%
6,872
-6,592
-49% -$65.1K
GGAL icon
1203
Galicia Financial Group
GGAL
$7.78B
$64K ﹤0.01%
6,616
+3,308
+100% +$28.2K
EWT icon
1204
iShares MSCI Taiwan ETF
EWT
$10.7B
$60K ﹤0.01%
1,516
+758
+100% +$28.2K
TEO icon
1205
Telecom Argentina
TEO
$5.97B
$56K ﹤0.01%
6,160
+3,080
+100% +$25.6K
GBT
1206
DELISTED
Global Blood Therapeutics, Inc.
GBT
$54K ﹤0.01%
850
+425
+100% +$29.2K
NATI
1207
DELISTED
National Instruments Corp
NATI
$48K ﹤0.01%
+1,228
New +$46.4K
NTLA icon
1208
Intellia Therapeutics
NTLA
$1.56B
$42K ﹤0.01%
2,040
+1,020
+100% +$17.3K
SGMO
1209
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$42K ﹤0.01%
4,600
+2,300
+100% +$21.3K
PRLB icon
1210
Protolabs
PRLB
$2.16B
$38K ﹤0.01%
330
+165
+100% +$16.9K
BLFS icon
1211
BioLife Solutions
BLFS
$1.67B
$36K ﹤0.01%
2,200
+1,100
+100% +$15.2K
MNDT
1212
DELISTED
Mandiant, Inc. Common Stock
MNDT
$36K ﹤0.01%
3,000
– –
EXP icon
1213
Eagle Materials
EXP
$6.59B
$32K ﹤0.01%
+462
New +$29.1K
IOVA icon
1214
Iovance Biotherapeutics
IOVA
$2.66B
$32K ﹤0.01%
1,200
+600
+100% +$19.7K
LAZ icon
1215
Lazard
LAZ
$4.29B
$30K ﹤0.01%
+1,016
New +$27.5K
SPN
1216
DELISTED
Superior Energy Services, Inc.
SPN
$30K ﹤0.01%
26,600
+13,300
+100% +$18.2K
ARWR icon
1217
Arrowhead Research
ARWR
$12.1B
$29K ﹤0.01%
+400
New +$14.1K
FL
1218
DELISTED
Foot Locker
FL
$26K ﹤0.01%
880
+440
+100% +$11.6K
RGNX icon
1219
Regenxbio
RGNX
$709M
$26K ﹤0.01%
720
+360
+100% +$13.4K
WAL icon
1220
Western Alliance Bancorporation
WAL
$8.97B
$22K ﹤0.01%
580
-32,947
-98% -$1.15M
MAT icon
1221
Mattel
MAT
$4.25B
$16K ﹤0.01%
1,690
+845
+100% +$7.67K
EVFM
1222
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$16K ﹤0.01%
+358
New +$24.1K
ADVM
1223
DELISTED
Adverum Biotechnologies
ADVM
$4K ﹤0.01%
20
+10
+100% +$1.77K
AWI icon
1224
Armstrong World Industries
AWI
$7.82B
$4K ﹤0.01%
58
-576
-91% -$43.7K
APOG icon
1225
Apogee Enterprises
APOG
$894M
– –
-8,450
Closed -$176K
47 48
49
50 51

Similar funds

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
Wealthfront Advisers
Wealthfront Advisers Palo Alto, California $45.6B AUM 18.83% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $47.7B AUM 29.41% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

KBC Group's Q2 2020 Portfolio in Review

As of Q2 2020, KBC Group held 1,348 positions worth $30.1B, up 152% from $11.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

KBC Group deployed $14.4B of net new capital in Q2 2020, opening 61 new positions and adding to 986 existing holdings. Its largest new stake was Trade Desk: 422,440 shares worth $17.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AutoZone, an estimated $19.9M trimmed.

  • KBC Group's largest Q2 2020 buy was Trade Desk: 422,440 shares worth $17.2M.
  • KBC Group added most to Microsoft in Q2 2020, an estimated $819M increase.
  • KBC Group's biggest Q2 2020 reduction was AutoZone, cutting an estimated $19.9M.
  • KBC Group fully exited Allergan plc in Q2 2020, selling an estimated $80.3M.
  • KBC Group's ten largest holdings make up 24% of its $30.1B portfolio in Q2 2020.
  • KBC Group opened 61 new positions and closed 82 in Q2 2020.
  • KBC Group's portfolio value rose 152% quarter-over-quarter to $30.1B.

Based on KBC Group's 13F filing for Q2 2020, filed 10 Aug 2020.